Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug

Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schiz...

Full description

Saved in:
Bibliographic Details
Published in:Organic process research & development 2022-03, Vol.26 (3), p.493-507
Main Authors: Bhosle, Siddhanath D, Itage, Shivanand V, Gangapuram, Balraju, Eppa, Gyanchander, Bhosale, Rajesh S, Yadav, Jhillu Singh
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653
cites cdi_FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653
container_end_page 507
container_issue 3
container_start_page 493
container_title Organic process research & development
container_volume 26
creator Bhosle, Siddhanath D
Itage, Shivanand V
Gangapuram, Balraju
Eppa, Gyanchander
Bhosale, Rajesh S
Yadav, Jhillu Singh
description Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.
doi_str_mv 10.1021/acs.oprd.1c00488
format article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acs_oprd_1c00488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a733944135</sourcerecordid><originalsourceid>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</originalsourceid><addsrcrecordid>eNp1kFtLwzAUx4MoOKfvPuYDrPUkadPsccwrDAQvoE_lmIvL0KYknaN-elu2V5_OH_4XDj9CLhnkDDi7Qp3y0EaTMw1QKHVEJqzkkJVKvh0PGpTIJJNwSs5S2gBAKRmfkPcn--PtjgZHn_umW9vOa7po2xhQr22iXdhhNHQwDn7yaQwvMfo24q9v7IxiQxdN59vU63UYB67j9vOcnDj8SvbicKfk9fbmZXmfrR7vHpaLVYZcQZfZsnDWCS2LCk3FhQQrBCipDaqKa-cY50phobkqiw_r5kbbuRForBTAZCmmBPa7OoaUonV1G_03xr5mUI9o6gFNPaKpD2iGymxfGZ1N2MZmePD_-B-QnWmd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</creator><creatorcontrib>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</creatorcontrib><description>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</description><identifier>ISSN: 1083-6160</identifier><identifier>EISSN: 1520-586X</identifier><identifier>DOI: 10.1021/acs.oprd.1c00488</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Organic process research &amp; development, 2022-03, Vol.26 (3), p.493-507</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</citedby><cites>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</cites><orcidid>0000-0002-6535-1704</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Bhosle, Siddhanath D</creatorcontrib><creatorcontrib>Itage, Shivanand V</creatorcontrib><creatorcontrib>Gangapuram, Balraju</creatorcontrib><creatorcontrib>Eppa, Gyanchander</creatorcontrib><creatorcontrib>Bhosale, Rajesh S</creatorcontrib><creatorcontrib>Yadav, Jhillu Singh</creatorcontrib><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><title>Organic process research &amp; development</title><addtitle>Org. Process Res. Dev</addtitle><description>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</description><issn>1083-6160</issn><issn>1520-586X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kFtLwzAUx4MoOKfvPuYDrPUkadPsccwrDAQvoE_lmIvL0KYknaN-elu2V5_OH_4XDj9CLhnkDDi7Qp3y0EaTMw1QKHVEJqzkkJVKvh0PGpTIJJNwSs5S2gBAKRmfkPcn--PtjgZHn_umW9vOa7po2xhQr22iXdhhNHQwDn7yaQwvMfo24q9v7IxiQxdN59vU63UYB67j9vOcnDj8SvbicKfk9fbmZXmfrR7vHpaLVYZcQZfZsnDWCS2LCk3FhQQrBCipDaqKa-cY50phobkqiw_r5kbbuRForBTAZCmmBPa7OoaUonV1G_03xr5mUI9o6gFNPaKpD2iGymxfGZ1N2MZmePD_-B-QnWmd</recordid><startdate>20220318</startdate><enddate>20220318</enddate><creator>Bhosle, Siddhanath D</creator><creator>Itage, Shivanand V</creator><creator>Gangapuram, Balraju</creator><creator>Eppa, Gyanchander</creator><creator>Bhosale, Rajesh S</creator><creator>Yadav, Jhillu Singh</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-6535-1704</orcidid></search><sort><creationdate>20220318</creationdate><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><author>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhosle, Siddhanath D</creatorcontrib><creatorcontrib>Itage, Shivanand V</creatorcontrib><creatorcontrib>Gangapuram, Balraju</creatorcontrib><creatorcontrib>Eppa, Gyanchander</creatorcontrib><creatorcontrib>Bhosale, Rajesh S</creatorcontrib><creatorcontrib>Yadav, Jhillu Singh</creatorcontrib><collection>CrossRef</collection><jtitle>Organic process research &amp; development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhosle, Siddhanath D</au><au>Itage, Shivanand V</au><au>Gangapuram, Balraju</au><au>Eppa, Gyanchander</au><au>Bhosale, Rajesh S</au><au>Yadav, Jhillu Singh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</atitle><jtitle>Organic process research &amp; development</jtitle><addtitle>Org. Process Res. Dev</addtitle><date>2022-03-18</date><risdate>2022</risdate><volume>26</volume><issue>3</issue><spage>493</spage><epage>507</epage><pages>493-507</pages><issn>1083-6160</issn><eissn>1520-586X</eissn><abstract>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</abstract><pub>American Chemical Society</pub><doi>10.1021/acs.oprd.1c00488</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-6535-1704</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1083-6160
ispartof Organic process research & development, 2022-03, Vol.26 (3), p.493-507
issn 1083-6160
1520-586X
language eng
recordid cdi_crossref_primary_10_1021_acs_oprd_1c00488
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
title Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A08%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20Synthetic%20Approaches%20toward%20the%20Synthesis%20of%20Cariprazine,%20an%20Antipsychotic%20Drug&rft.jtitle=Organic%20process%20research%20&%20development&rft.au=Bhosle,%20Siddhanath%20D&rft.date=2022-03-18&rft.volume=26&rft.issue=3&rft.spage=493&rft.epage=507&rft.pages=493-507&rft.issn=1083-6160&rft.eissn=1520-586X&rft_id=info:doi/10.1021/acs.oprd.1c00488&rft_dat=%3Cacs_cross%3Ea733944135%3C/acs_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true